Page last updated: 2024-11-05

thiopropazate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiopropazate: minor descriptor (66-72); major descriptor (73-85); on-line search PHENOTHIAZINES (66-85); Index Medicus search PHENOTHIAZINES (66-72); THIOPROPAZATE (73-85); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

thiopropazate : A phenothiazine derivative in which 10H-phenothiazine has a chloro subsitituent at the 2-position and a 3-[4-(2-acetoxyethyl)piperazin-1-yl]propyl group at N-10. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6762
CHEMBL ID1697851
CHEBI ID59119
SCHEMBL ID144729
MeSH IDM0262950

Synonyms (50)

Synonym
tiopropazato
thiopropazatum
CHEBI:59119 ,
2-(4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]-1-piperazinyl)ethyl acetate
1-piperazineethanol, 4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]-, acetate (ester)
thiopropazate
84-06-0
2-{4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]piperazin-1-yl}ethyl acetate
1-(2-acetoxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
hsdb 3401
2-chloro-10-(3-(1-(2-acetoxyethyl)-4-piperazinyl)propyl)phenothiazine
thiopropazat
1-piperazineethanol, 4-(3-(2-chloro-10h-phenothiazin-10-yl)propyl)-, acetate (ester)
perphenazine acetate
10-(3-(1-(2-acetoxyethyl)-4-piperazinyl)propyl)-2-chlorophenothiazine
sc 7105
4-(3-(2-chlorophenothiazin-10-yl)propyl)-1-piperazineethanol acetate
dartalan
n-(beta-acetoxyethyl)-n'-(gamma-(2'-chloro-10'-phenothiazinyl)propyl)piperazine
1-piperazineethanol, 4-(3-(2-chlorophenothiazin-10-yl)propyl)-, acetate (ester)
thiopropazatum [inn-latin]
dartal
einecs 201-513-4
tiopropazato [inn-spanish]
2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl acetate
D09216
thiopropazate (inn)
CHEMBL1697851
0jfy081q2x ,
unii-0jfy081q2x
thiopropazate [inn:ban]
thiopropazate [who-dd]
thiopropazate [mi]
thiopropazate [inn]
thiopropazate [hsdb]
SCHEMBL144729
1-piperazineethanol, 4-(3-(2-chlorophenothiazin-10-yl)propyl)-, acetate
2-chloro-10-[3-[1-(2-acetoxyethyl)-4-piperazinyl]propyl]phenothiazine
10-[3-[4-(2-acetoxyethyl)-1-piperazinyl]propyl]-2-chlorophenothiazine
n-(.beta.-acetoxyethyl)-n'-(.gamma.-(2'-chloro-10'-phenothiazinyl)propyl)piperazine
AIUHRQHVWSUTGJ-UHFFFAOYSA-N
1-piperazineethanol, 4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]-, acetate
2-(4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]-1-piperazinyl)ethyl acetate #
1-piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, acetate (ester)
1-(2-acetoxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine
DTXSID6023654
HY-101614
CS-6585
DB13557
Q7784690
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
phenothiazine antipsychotic drugnull
dopaminergic antagonistA drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
phenothiazines
N-alkylpiperazine
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (94.12)18.7374
1990's0 (0.00)18.2507
2000's1 (5.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.82 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.56%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]